![Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs) - QFR Solutions Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs) - QFR Solutions](https://www.qfrsolutions.com/wp-content/uploads/2017/12/Aclaris.jpg)
Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs) - QFR Solutions
![Eskata (hydrogen peroxide) for the Treatment of Raised Seborrheic Keratoses (SK), USA - Clinical Trials Arena Eskata (hydrogen peroxide) for the Treatment of Raised Seborrheic Keratoses (SK), USA - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/2l-image-Eskata.jpg)
Eskata (hydrogen peroxide) for the Treatment of Raised Seborrheic Keratoses (SK), USA - Clinical Trials Arena
![Susan H. Weinkle, M.D. - Dermatologist - Bradenton, Florida - ESKATA - Susan H. Weinkle, M.D. - Dermatologist - Bradenton, Florida Susan H. Weinkle, M.D. - Dermatologist - Bradenton, Florida - ESKATA - Susan H. Weinkle, M.D. - Dermatologist - Bradenton, Florida](https://cdcssl.ibsrv.net/ibimg/smb/600x158_80/webmgr/1q/r/9/eskata-pen.png.webp?aa562e3e6c74104ff603740cc5108155)